MiR-326 regulates EphB3 to inhibit invasion and metastasis of breast cancer cells
- Author:
Xin-Lu CHEN
1
;
Lin CHEN
1
;
Yan-Qiao ZHAO
1
;
Lu LIU
1
;
Wei ZUO
2
;
Hong-Li LI
3
;
Cheng-De LI
4
;
Chong-Gao YIN
5
Author Information
- Publication Type:Journal Article
- Keywords: breast cancer; EphB3; invasion; migration; MiR-326; proliferation
- From: Chinese Pharmacological Bulletin 2023;39(4):665-672
- CountryChina
- Language:Chinese
- Abstract: ;Aim To investigate the molecular mechanism of miR-326 inhibiting breast cancer invasion and metastasis by regulating EphB3 expression. Methods RTFQ-PCR was used to examine the expression of miR-326 in normal breast epithelial cells and breast cancer cells and the transfection efficiency of miR-326 overexpression plasmid. EdU cell proliferation assay and Transwell assay were used to examine the changes in proliferation, migration and invasion ability of different subgroups of cells. Dual luciferase assay was used to verify the presence of binding sites for miR-326 and EphB3. Western blot was used to detect the expression of EphB3 in breast cancer cells after overexpression of miR-326. Results RTFQ-PCR results showed that miR-326 was lowly expressed in breast cancer cells and successfully transfected (P < 0. 05). EdU proliferation assay and Transwell assay results showed that overexpression of miR-326 in breast cancer cells inhibited proliferation, migration and invasive ability (P < 0. 05). The results of dual luciferase assay showed that miR-326 could interact with the 3'-UTR of EphB3 (P < 0. 05). Western blot and Transwell assays showed that miR-326 could negatively regulate EphB3 to inhibit invasive metastasis of breast cancer cells (P < 0. 05). Conclusions MiR-326 acts as a cancer suppressor genes in the development of breast cancer and suppresses the invasion and metastasis of breast cancer cells by regulating the expression of EphB3.
